20 AIDX
NASDAQ AIDX
$0.56 -0.01 (-2.32%)
As of: Sep 9, 2026 · 1:45 PM EDT

20 (AIDX) Convertible Debt (2025 - 2026)

20's (AIDX) quarterly Convertible Debt came in at $570000.0 in Q1 2026, down 7.97% quarter-over-quarter from $619355.0 in Q4 2025.

Analysis

20 (AIDX) Convertible Debt (2025 - 2026) Analysis & Trends

20 (AIDX) has reported Convertible Debt for 2 consecutive years, with $570000.0 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Convertible Debt changed N/A year-over-year to $570000.0; the trailing twelve-month figure through Mar 2026 stood at $570000.0 (changed N/A YoY), and the FY2025 full-year result was $619355.0, changed N/A from the prior year.
  • Convertible Debt declined to $570000.0 in Q1 2026 per AIDX's latest filing, from $619355.0 in the prior quarter.
  • Across five years, Convertible Debt topped out at $619355.0 in Q4 2025 and bottomed at $570000.0 in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 47.08 Bn 45.98 Bn 486.15 Mn
2 Labcorp Holdings 26.13 Bn 25.99 Bn 1.11 Bn
3 Quest Diagnostics 25.90 Bn 25.27 Bn 1.03 Bn
4 Guardant Health 21.89 Bn 20.84 Bn 219.03 Mn
5 Tempus AI 11.21 Bn 10.39 Bn 274.25 Mn
6 Caris Life Sciences 6.94 Bn 6.15 Bn 182.38 Mn
7 Sotera Health 5.22 Bn 4.86 Bn 177.96 Mn
8 BillionToOne 4.78 Bn 4.23 Bn 77.11 Mn
9 iRhythm Holdings 3.96 Bn 3.37 Bn 163.21 Mn
10 20 6.09 Mn 1.55 Mn 304,727.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 570,000.00
Dec 31, 2025 619,355.00